|
1
|
Torre LA, Trabert B, DeSantis CE, Miller
KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A and Siegel RL:
Ovarian cancer statistics, 2018. CA Cancer J Clin. 68:284–296.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lheureux S, Braunstein M and Oza AM:
Epithelial ovarian cancer: Evolution of management in the era of
precision medicine. CA Cancer J Clin. 69:280–304. 2019.PubMed/NCBI
|
|
4
|
Partridge EE and Barnes MN: Epithelial
ovarian cancer: Prevention, diagnosis, and treatment. CA Cancer J
Clin. 49:297–320. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim JY, Cho CH and Song HS: Targeted
therapy of ovarian cancer including immune check point inhibitor.
Korean J Intern Med (Korean Assoc Intern Med). 32:798–804.
2017.
|
|
6
|
Kroeger PT Jr and Drapkin R: Pathogenesis
and heterogeneity of ovarian cancer. Curr Opin Obstet Gynecol.
29:26–34. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dong X, Men X, Zhang W and Lei P: Advances
in tumor markers of ovarian cancer for early diagnosis. Indian J
Cancer. 51 (Suppl 3):e72–e76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang WL, Lu Z and Bast RC Jr: The role of
biomarkers in the management of epithelial ovarian cancer. Expert
Rev Mol Diagn. 17:577–591. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bordoloi D, Banik K, Shabnam B, Padmavathi
G, Monisha J, Arfuso F, Dharmarajan A, Mao X, Lim LHK, Wang L, et
al: TIPE family of proteins and its implications in different
chronic diseases. Int J Mol Sci. 19:192018. View Article : Google Scholar
|
|
10
|
Jiang J, Pang X, Liu H, Yang X, Zhang Y,
Xiang X, Li J, Li T and Zhao P: Reduced TIPE2 expression is
inversely associated with proinflammatory cytokines and positively
correlated with bone mineral density in patients with osteoporosis.
Life Sci. 216:227–232. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Q, Ma L, Liu T, Ge C, Zhou Q, Wei C
and Shi W: TIPE2 suppresses Pseudomonas aeruginosa keratitis by
inhibiting NF-kappaB signaling and the infiltration of inflammatory
cells. J Infect Dis. 220:1008–1018. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu Y, Ni XY, Chen RL, Li J and Gao FG:
TIPE attenuates the apoptotic effect of radiation and cisplatin and
promotes tumor growth via JNK and p38 activation in Raw264.7 and
EL4 cells. Oncol Rep. 39:2688–2694. 2018.PubMed/NCBI
|
|
13
|
Padmavathi G, Banik K, Monisha J, Bordoloi
D, Shabnam B, Arfuso F, Sethi G, Fan L and Kunnumakkara AB: Novel
tumor necrosis factor-α induced protein eight (TNFAIP8/TIPE)
family: Functions and downstream targets involved in cancer
progression. Cancer Lett. 432:260–271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang Z, Liang X, Gao L, Ma H, Liu X, Pan
Y, Yan W, Shan H, Wang Z, Chen YH, et al: TIPE1 induces apoptosis
by negatively regulating Rac1 activation in hepatocellular
carcinoma cells. Oncogene. 34:2566–2574. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wu X, Ma Y, Cheng J, Li X, Zheng H, Jiang
L and Zhou R: TIPE1 function as a prognosis predictor and negative
regulator of lung cancer. Oncotarget. 8:78496–78506. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu W, Chen Y, Xie H, Guo Y, Ren D, Li Y,
Jing X, Li D, Wang X, Zhao M, et al: TIPE1 suppresses invasion and
migration through down-regulating Wnt/β-catenin pathway in gastric
cancer. J Cell Mol Med. 22:1103–1117. 2018.PubMed/NCBI
|
|
17
|
Zhao P, Pang X, Jiang J, Wang L, Zhu X,
Yin Y, Zhai Q, Xiang X, Feng F and Xu W: TIPE1 promotes cervical
cancer progression by repression of p53 acetylation and is
associated with poor cervical cancer outcome. Carcinogenesis.
40:592–599. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen P, Zhou J, Li J, Zhang Q and Zuo Q:
TIPE1 suppresses osteosarcoma tumor growth by regulating macrophage
infiltration. Clin Transl Oncol. 21:334–341. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dai L, Cui X, Zhang X, Cheng L, Liu Y,
Yang Y, Fan P, Wang Q, Lin Y, Zhang J, et al: SARI inhibits
angiogenesis and tumour growth of human colon cancer through
directly targeting ceruloplasmin. Nat Commun. 7:119962016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ujiie D, Okayama H, Saito K, Ashizawa M,
Min AK, Endo E, Kase K, Yamada L, Kikuchi T, Hanayama H, et al:
KRT17 as a prognostic biomarker for stage II colorectal cancer.
Carcinogenesis. 41:591–599. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bao L, You B, Shi S, Shan Y, Zhang Q, Yue
H, Zhang J, Zhang W, Shi Y, Liu Y, et al: Metastasis-associated
miR-23a from nasopharyngeal carcinoma-derived exosomes mediates
angiogenesis by repressing a novel target gene TSGA10. Oncogene.
37:2873–2889. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cui J, Zhang G, Hao C, Wang Y, Lou Y,
Zhang W, Wang J and Liu S: The expression of TIPE1 in murine
tissues and human cell lines. Mol Immunol. 48:1548–1555. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Y, Liu Y, Hu C, Ni X and Huang X:
Tumor necrosis factor α-induced protein 8-like 1 promotes apoptosis
by regulating B-cell leukemia/lymphoma-2 family proteins in
RAW264.7 cells. Oncol Lett. 12:3506–3512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luan YY, Zhang L, Zhu FJ, Dong N, Lu JY
and Yao YM: Effect of TIPE1 on immune function of dendritic cells
and its signaling pathway in septic mice. J Infect Dis.
220:699–709. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ye T, Yang B, Wang C, Su C, Luo J, Yang X,
Yu H, Yuan Z, Meng Z and Xia J: TIPE1 impairs stemness maintenance
in colorectal cancer through directly targeting β-catenin.
Carcinogenesis. 41:25–35. 2020.PubMed/NCBI
|
|
27
|
Hu W, Feng CM, Liu LY, Li N, Tian F, Du
JX, Zhao Y, Xiang XX, Liu K and Zhao PQ: TIPE1 inhibits breast
cancer proliferation by downregulating ERK phosphorylation and
predicts a favorable prognosis. Front Oncol. 9:4002019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tong Y, Zhang G, Li Y, Xu J, Yuan J, Zhang
B, Hu T and Song G: Corilagin inhibits breast cancer growth via
reactive oxygen species-dependent apoptosis and autophagy. J Cell
Mol Med. 22:3795–3807. 2018. View Article : Google Scholar
|
|
29
|
Yan XY, Zhong XR, Yu SH, Zhang LC, Liu YN,
Zhang Y, Sun LK and Su J: p62 aggregates mediated caspase 8
activation is responsible for progression of ovarian cancer. J Cell
Mol Med. 23:4030–4042. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Seo JA, Kim B, Dhanasekaran DN, Tsang BK
and Song YS: Curcumin induces apoptosis by inhibiting
sarco/endoplasmic reticulum Ca2+ ATPase activity in
ovarian cancer cells. Cancer Lett. 371:30–37. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang H, Luo Y, Qiao T, Wu Z and Huang Z:
Luteolin sensitizes the antitumor effect of cisplatin in
drug-resistant ovarian cancer via induction of apoptosis and
inhibition of cell migration and invasion. J Ovarian Res.
11:932018. View Article : Google Scholar : PubMed/NCBI
|
